ALABAMA STATE BOARD OF MEDICAL EXAMINERS RULES & REGULATIONS
540-X-4-.06 Controlled Substances Prescription Guidelines for Physicians.
(1) All prescriptions for controlled substances shall meet the following requirements:
(a) The prescription shall be dated as of, and signed on, the day when issued;
(b) The prescription shall bear the full name and address of the patient to whom the drug is prescribed;
(c) The prescription shall bear the drug name, strength, dosage form, and quantity prescribed;
(d) The prescription shall bear directions for use of the drug;
(e) The prescription shall bear the name, address and Alabama Controlled Substances Certificate number of the physician prescribing the drug;
(2) Where an oral order is not permitted, prescriptions for controlled substances shall be written with ink or indelible pencil or typewriter and shall be manually signed by the physician issuing the prescription. For purposes of this rule, “manually signed” requires a non-electronic, handwritten signature. Oral orders are not permitted for prescriptions for Schedule II and Schedule IIN controlled substances.
(3) A prescription issued by a physician may be communicated to a pharmacist by an employee or agent of the physician.
(4) A prescription may be prepared by an employee or agent of the physician for the signature of the prescribing physician; however, the prescribing physician is ultimately responsible for insuring that the prescription meets the requirements of this regulation.
(5) When a physician prescribes a controlled substance, he or she shall not delegate the responsibility of determining the type, dosage form, frequency of application and number of refills of the drug prescribed.
(6) Every written prescription for a controlled substance issued by a physician shall contain two signature lines. Under one signature line shall be printed clearly the words “dispense as written.” Under the other signature line shall be printed clearly the words “product selection permitted.” The prescribing physician shall communicate instructions to the pharmacist by entering his or her non-electronic, handwritten signature on the appropriate line.
(7) It is improper for any prescription for a controlled substance to be signed by any person in the place of or on behalf of the prescribing physician.
(8) It is improper, under any circumstances, for a physician to pre-sign blank prescription pads or forms and make them available to employees or support personnel.
(9) It is improper for a physician to utilize blank prescription pads or forms upon which the signature of the physician has been mechanically or photostatically reproduced.
(10) The Board may assess an administrative fine not to exceed ten thousand dollars ($10,000.00) for each separate violation or failure to comply with the prescription guidelines provided in this rule.
All rights reserved